NCT01748344View on ClinicalTrials.gov

Phase II Study Evaluating ONO-4053 and Cetirizine in Subjects With Seasonal Allergic Rhinitis

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

February 28, 2014

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

Cetirizine

10mg tablets

DRUG

High dose ONO-4053

Experimental

DRUG

Low dose ONO-4053

Experimental

DRUG

Placebo

None active

Trial Locations (1)

Unknown

Vienna Clinical Site, Vienna

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY